Solution formulation and lyophilisation of a recombinant fibronectin fragment

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 67, Issue 2, 2007, Pages 309-319

  Pereira, P ^a   Kelly, S M ^b   Cooper, A ^b   Mardon, H J ^c   Gellert, P R ^d   van der Walle, C F ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d ASTRAZENECA   (United Kingdom)

Author keywords

Calorimetry; Cell adhesion; Circular dichroism; Fibronectin; Formulation; Thermal stability

Indexed keywords

FIBRONECTIN; FIBRONECTIN TYPE III; GUANIDINE; MACROGOL 6000; RECOMBINANT FIBRONECTIN; SUCROSE; UNCLASSIFIED DRUG; VASCULAR TARGETING AGENT;

ARTICLE; CALORIMETRY; CELL ADHESION; CIRCULAR DICHROISM; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; ESCHERICHIA COLI; FLUORESCENCE SPECTROSCOPY; FREEZE DRYING; NONHUMAN; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN PURIFICATION; SPECTROSCOPY; STRUCTURE ACTIVITY RELATION; THERMOSTABILITY; TISSUE ENGINEERING; TUMOR BLOOD FLOW; VASCULARIZATION;

ANIMALS; CALORIMETRY; CALORIMETRY, DIFFERENTIAL SCANNING; CELL ADHESION; CIRCULAR DICHROISM; CRICETINAE; FIBRONECTINS; HEAT; HYDROGEN-ION CONCENTRATION; POLYETHYLENE GLYCOLS; RECOMBINANT FUSION PROTEINS; SPECTROMETRY, FLUORESCENCE; STRUCTURE-ACTIVITY RELATIONSHIP; SUCROSE; TISSUE ENGINEERING;

EID: 34547697312     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2007.03.009     Document Type: Article

References (31)

1. Mardon H.J., and Grant K.E. The role of the ninth and tenth type III domains of human fibronectin in cell adhesion. FEBS Lett. 340 (1994) 197-201
2. Cutler S.M., and Garcia A.J. Engineering cell adhesive surfaces that direct integrin alpha5beta1 binding using a recombinant fragment of fibronectin. Biomaterials 24 (2003) 1759-1770
3. Kim S., Bell K., Mousa S.A., and Varner J.A. Regulation of angiogenesis in vivo by ligation of integrin alpha5beta1 with the central cell-binding domain of fibronectin. Am. J. Pathol. 156 (2000) 1345-1362
4. Aplin J.D., Haigh T., Jones C.J., Church H.J., and Vicovac L. Development of cytotrophoblast columns from explanted first-trimester human placental villi: role of fibronectin and integrin alpha5beta1. Biol. Reprod. 60 (1999) 828-838
5. van der Walle C.F., Altroff H., and Mardon H.J. Novel mutant human fibronectin FIII9-10 domain pair with increased conformational stability and biological activity. Protein Eng. 15 (2002) 1021-1024
6. Kendrick B.S., Chang B.S., Arakawa T., Peterson B., Randolph T.W., Manning M.C., and Carpenter J.F. Preferential exclusion of sucrose from recombinant interleukin-1 receptor antagonist: role in restricted conformational mobility and compaction of native state. Proc. Natl. Acad. Sci. USA 94 (1997) 11917-11922
7. Lee J.C., and Timasheff S.N. The stabilization of proteins by sucrose. J. Biol. Chem. 256 (1981) 7193-7201
8. Allison S.D., Chang B., Randolph T.W., and Carpenter J.F. Hydrogen bonding between sugar and protein is responsible for inhibition of dehydration-induced protein unfolding. Arch. Biochem. Biophys. 365 (1999) 289-298
9. Wang W. Instability, stabilization, and formulation of liquid protein pharmaceuticals. Int. J. Pharm. 185 (1999) 129-188
10. Cooper A., Kennedy M.W., Fleming R.I., Wilson E.H., Videler H., Wokosin D.L., Su T.J., Green R.J., and Lu J.R. Adsorption of frog foam nest proteins at the air-water interface. Biophys. J. 88 (2005) 2114-2125
11. Branchu S., Forbes R.T., York P., and Nyqvist H. A central composite design to investigate the thermal stabilization of lysozyme. Pharm. Res. 16 (1999) 702-708
12. Cueto M., Dorta M.J., Munguia O., and Llabres M. New approach to stability assessment of protein solution formulations by differential scanning calorimetry. Int. J. Pharm. 252 (2003) 159-166
13. Griko Y., Sreerama N., Osumi-Davis P., Woody R.W., and Woody A.Y. Thermal and urea-induced unfolding in T7 RNA polymerase: calorimetry, circular dichroism and fluorescence study. Protein Sci. 10 (2001) 845-853
14. Copie V., Tomita Y., Akiyama S.K., Aota S., Yamada K.M., Venable R.M., Pastor R.W., Krueger S., and Torchia D.A. Solution structure and dynamics of linked cell attachment modules of mouse fibronectin containing the RGD and synergy regions: comparison with the human fibronectin crystal structure. J. Mol. Biol. 277 (1998) 663-682
15. Leahy D.J., Aukhil I., and Erickson H.P. 2.0 A crystal structure of a four-domain segment of human fibronectin encompassing the RGD loop and synergy region. Cell 84 (1996) 155-164
16. Stevens E.S., Morris E.R., Charlton J.A., and Rees D.A. Vacuum ultraviolet circular dichroism of fibronectin. Dominant tyrosine effects. J. Mol. Biol. 197 (1987) 743-745
17. Khan M.Y., Villanueva G., and Newman S.A. On the origin of the positive band in the far-ultraviolet circular dichroic spectrum of fibronectin. J. Biol. Chem. 264 (1989) 2139-2142
18. Wang W. Lyophilization and development of solid protein pharmaceuticals. Int. J. Pharm. 203 (2000) 1-60
19. Tang X.L., and Pikal M.J. Design of freeze-drying processes for pharmaceuticals: practical advice. Pharm. Res. 21 (2004) 191-200
20. Hill J.J., Shalaev E.Y., and Zografi G. Thermodynamic and dynamic factors involved in the stability of native protein structure in amorphous solids in relation to levels of hydration. J. Pharm. Sci. 94 (2005) 1636-1667
21. Chang L.Q., Shepherd D., Sun J., Ouellette D., Grant K.L., Tang X.L., and Pikal M.J. Mechanism of protein stabilization by sugars during freeze-drying and storage: native structure preservation, specific interaction, and/or immobilization in a glassy matrix?. J. Pharm. Sci. 94 (2005) 1427-1444
22. Annan W.S., Fairhead M., Pereira P., and van der Walle C.F. Emulsifying performance of modular {beta}-sandwich proteins: the hydrophobic moment and conformational stability. Protein Eng. Des. Sel. 19 (2006) 537-545
23. Altroff H., Schlinkert R., van der Walle C.F., Bernini A., Campbell I.D., Werner J.M., and Mardon H.J. Interdomain tilt angle determines integrin-dependent function of the ninth and tenth FIII domains of human fibronectin. J. Biol. Chem. 279 (2004) 55995-56003
24. Pierschbacher M.D., and Ruoslahti E. Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 309 (1984) 30-33
25. Spitzfaden C., Grant R.P., Mardon H.J., and Campbell I.D. Module-module interactions in the cell binding region of fibronectin: stability, flexibility and specificity. J. Mol. Biol. 265 (1997) 565-579
26. Plaxco K.W., Spitzfaden C., Campbell I.D., and Dobson C.M. A comparison of the folding kinetics and thermodynamics of two homologous fibronectin type III modules. J. Mol. Biol. 270 (1997) 763-770
27. Farruggia B., Nerli B., Di Nuci H., Rigatusso R., and Pico G. Thermal features of the bovine serum albumin unfolding by polyethylene glycols. Int. J. Biol. Macromol. 26 (1999) 23-33
28. Lumry R., and Eyring H. Conformation changes of proteins. J. Phys. Chem. 58 (1954) 110-120
29. Ringe D., and Petsko G.A. The 'glass transition' in protein dynamics: what it is, why it occurs, and how to exploit it. Biophys. Chem. 105 (2003) 667-680
30. Franks F. Solid aqueous-solutions. Pure Appl. Chem. 65 (1993) 2527-2537
31. Altroff H., van der Walle C.F., Asselin J., Fairless R., Campbell I.D., and Mardon H.J. The eighth FIII domain of human fibronectin promotes integrin alpha5beta1 binding via stabilization of the ninth FIII domain. J. Biol. Chem. 276 (2001) 38885-38892